Novel approaches to support therapeutic development in ultra-rare cancers
This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.
This is a forecasted FDA funding opportunity supporting novel approaches to advance therapeutic development for ultra-rare cancers. It is expected to target research institutions and organizations …
- Deadline
- Not specified
- Posted
- Aug 4, 2025
- Award amount
- Amount not specified
In plain English
This is a forecasted FDA funding opportunity supporting novel approaches to advance therapeutic development for ultra-rare cancers. It is expected to target research institutions and organizations working in oncology drug development; full eligibility, funding amounts, and deadlines have not yet been published. Interested applicants should monitor the FDA for the formal notice.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants from Food and Drug Administration — soonest deadline first.
Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Food and Drug Administration · Amount varies · No deadline listed
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
Food and Drug Administration · Amount varies · No deadline listed
Studies Addressing Rare Neurodegenerative Diseases including ALS
Food and Drug Administration · Amount varies · No deadline listed
Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed
Food and Drug Administration · Amount varies · No deadline listed
Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)
Food and Drug Administration · Amount varies · No deadline listed
Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed
Food and Drug Administration · Amount varies · No deadline listed
Also listed under Food and Drug Administration.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.